NCNA
Price
$2.84
Change
-$0.20 (-6.58%)
Updated
Sep 4, 02:22 PM (EDT)
Capitalization
5.8M
TOVX
Price
$0.43
Change
+$0.02 (+4.88%)
Updated
Sep 3 closing price
Capitalization
4.13M
Interact to see
Advertisement

NCNA vs TOVX

Header iconNCNA vs TOVX Comparison
Open Charts NCNA vs TOVXBanner chart's image
NuCana
Price$2.84
Change-$0.20 (-6.58%)
Volume$300
Capitalization5.8M
Theriva Biologics
Price$0.43
Change+$0.02 (+4.88%)
Volume$1.57M
Capitalization4.13M
NCNA vs TOVX Comparison Chart in %
Loading...
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TOVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NCNA vs. TOVX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NCNA is a Hold and TOVX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (NCNA: $3.04 vs. TOVX: $0.43)
Brand notoriety: NCNA and TOVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NCNA: 47% vs. TOVX: 243%
Market capitalization -- NCNA: $5.8M vs. TOVX: $4.13M
NCNA [@Biotechnology] is valued at $5.8M. TOVX’s [@Biotechnology] market capitalization is $4.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NCNA’s FA Score shows that 1 FA rating(s) are green whileTOVX’s FA Score has 1 green FA rating(s).

  • NCNA’s FA Score: 1 green, 4 red.
  • TOVX’s FA Score: 1 green, 4 red.
According to our system of comparison, both NCNA and TOVX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NCNA’s TA Score shows that 5 TA indicator(s) are bullish while TOVX’s TA Score has 5 bullish TA indicator(s).

  • NCNA’s TA Score: 5 bullish, 3 bearish.
  • TOVX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both NCNA and TOVX are a good buy in the short-term.

Price Growth

NCNA (@Biotechnology) experienced а -6.17% price change this week, while TOVX (@Biotechnology) price change was +2.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.72%. For the same industry, the average monthly price growth was +5.89%, and the average quarterly price growth was +27.73%.

Industries' Descriptions

@Biotechnology (-0.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NCNA($5.8M) has a higher market cap than TOVX($4.13M). TOVX YTD gains are higher at: -75.429 vs. NCNA (-98.723).
NCNATOVXNCNA / TOVX
Capitalization5.8M4.13M141%
EBITDAN/A-27.05M-
Gain YTD-98.723-75.429131%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A12.1M-
Total DebtN/A2.89M-
FUNDAMENTALS RATINGS
NCNA vs TOVX: Fundamental Ratings
NCNA
TOVX
OUTLOOK RATING
1..100
5186
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
9
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
9892
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TOVX's Valuation (9) in the null industry is in the same range as NCNA (11) in the Biotechnology industry. This means that TOVX’s stock grew similarly to NCNA’s over the last 12 months.

TOVX's Profit vs Risk Rating (100) in the null industry is in the same range as NCNA (100) in the Biotechnology industry. This means that TOVX’s stock grew similarly to NCNA’s over the last 12 months.

TOVX's SMR Rating (99) in the null industry is in the same range as NCNA (100) in the Biotechnology industry. This means that TOVX’s stock grew similarly to NCNA’s over the last 12 months.

TOVX's Price Growth Rating (92) in the null industry is in the same range as NCNA (98) in the Biotechnology industry. This means that TOVX’s stock grew similarly to NCNA’s over the last 12 months.

TOVX's P/E Growth Rating (100) in the null industry is in the same range as NCNA (100) in the Biotechnology industry. This means that TOVX’s stock grew similarly to NCNA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NCNATOVX
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
78%
Bullish Trend 23 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TOVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLDB5.750.32
+5.89%
Solid Biosciences
ANIP94.920.82
+0.87%
ANI Pharmaceuticals
UFI4.37-0.02
-0.46%
UNIFI
OWL17.91-0.53
-2.87%
Blue Owl Capital
RELI0.87-0.03
-3.71%
Reliance Global Group Inc.

NCNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NCNA has been closely correlated with CDTX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if NCNA jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NCNA
1D Price
Change %
NCNA100%
+2.01%
CDTX - NCNA
93%
Closely correlated
-0.56%
NBY - NCNA
92%
Closely correlated
+17.54%
RNAC - NCNA
92%
Closely correlated
+4.17%
TAOX - NCNA
92%
Closely correlated
-3.38%
AGEN - NCNA
92%
Closely correlated
+2.40%
More

TOVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TOVX has been loosely correlated with SER. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if TOVX jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TOVX
1D Price
Change %
TOVX100%
+5.44%
SER - TOVX
34%
Loosely correlated
-0.38%
XTLB - TOVX
29%
Poorly correlated
-0.84%
LABFF - TOVX
27%
Poorly correlated
N/A
VOR - TOVX
24%
Poorly correlated
-1.96%
NCNA - TOVX
24%
Poorly correlated
+2.01%
More